Skip to content
MBRXMoleculin Biotech, Inc.

Earnings

When Moleculin Biotech, Inc. reports, what it reported each quarter, and how the stock took the results.

44 quarters. Sep 30, 2015 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

10-K due Mar 15 – 26

No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 8 filings.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 15 – 26

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$0.00
Revenue, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
Net income
$15.55M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2021 n/m, Q2 2021 n/m, Q1 2021 n/m, Q3 2020 n/m

Quarter by quarter

Q3 2026$0.00No Q3 2025 on file

Latest results

  1. Q3 2026Nov 13, 2026, after the close
    Revenue
    $0.00
    —
    Net income
    -$6.49M
    N/M
    EPS
    —
    —
  2. Q2 2026Aug 13, 2026, after the close+5.8%by the close of Aug 14
    Revenue
    $0.00
    —
    Net income
    -$7.64M
    N/M
    EPS
    —
    —
  3. Q1 2026May 14, 2026, after the close4.1%by the close of May 15
    Revenue
    $0.00
    —
    Net income
    -$12.85M
    N/M
    EPS
    —
    —
  4. Q4 2025Mar 18, 2026, after the close1.0%by the close of Mar 19
    Revenue
    $0.00
    —
    Net income
    $15.55M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026—Nov 13, 202644 d10-Q$0.00———
Q2 2026Jun 30, 2026—Aug 13, 202644 d10-Q$0.00——+5.8%
Q1 2026Mar 31, 2026—May 14, 202644 d10-Q$0.00——4.1%
FY 2025
Q4 2025derivedDec 31, 2025—Mar 18, 202677 d10-K$0.00——1.0%
Q3 2025Sep 30, 2025—Nov 13, 202544 d10-Q$0.00——4.4%
Q2 2025Jun 30, 2025—Aug 12, 202543 d10-Q$0.00——+1.5%
Q1 2025Mar 31, 2025—May 13, 202543 d10-Q$0.00——6.1%
FY 2024
Q4 2024derivedDec 31, 2024—Mar 21, 202580 d10-K$0.00——3.6%
Q3 2024Sep 30, 2024—Nov 8, 202439 d10-Q$0.00——0.4%
Q2 2024Jun 30, 2024—Aug 13, 202444 d10-Q$0.00——+10.1%
Q1 2024Mar 31, 2024—May 10, 202440 d10-Q$0.00——4.5%
Earlier years, FY 2015 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 13, 2026036901
10-QAug 13, 2026027688
10-QMay 14, 2026017034
10-KMar 18, 2026008841
10-QNov 13, 2025034839
10-QAug 12, 2025026225
10-QMay 13, 2025016466
10-KMar 21, 2025008751
10-QNov 8, 2024034236
10-QAug 13, 2024026367

Provenance

ProvenanceData status and checks

Moleculin Biotech, Inc. · CIK 1659617 · Engraved from SEC EDGAR